Last reviewed · How we verify

NCT06630767

Enhanced Recovery After Surgery Program Versus Conventional Care for Laparoscopic Common Bile Duct Exploration

Completed NA Last updated 15 October 2024
What this trial tests

NA trial testing ERAS in Choledocholithiasis in 228 participants. Completed in 30 June 2024.

Timeline
1 January 2021
Primary endpoint
30 June 2024
30 June 2024

Quick facts

Lead sponsorSouth Valley University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment228
Start date1 January 2021
Primary completion30 June 2024
Estimated completion30 June 2024
Sites2 locations across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

South Valley University

Who can join

Adults 20 to 70, any sex, with Choledocholithiasis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Laparoscopic common bile duct exploration (LCBDE) is a minimally invasive procedure to treat common bile duct stones (CBDS). Perioperative anxiety, hunger, thirst, fatigue, pain, nausea, and vomiting can influence a patient's recovery after surgery and prolong the in-hospital stay. Enhanced Recovery After Surgery (ERAS) is a modern concept that aims to improve perioperative patient care by implementing an evidence-based, patient-centered team approach. However, few reports focused on the safety and efficacy of the ERAS program in LCBDE. Therefore, this paper aims to compare the outcome of the ERAS program and conventional (C) care for patients undergoing LCBDE

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of ERAS

Trials testing the same drug.

Other recruiting trials for Choledocholithiasis

Currently open trials in the same condition.

Other South Valley University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06630767.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing